Valganciclovir Hydrochloride Powder, For Solution
Product Images NDC 27241-159

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 27241-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Valgacyclovir Structure)

Chemical structure of Valganciclovir hydrochloride depicted in a molecular diagram showing atoms and bonds representative of the compound.*

FDA Label Image

Valganciclovir 50mg

Label for Valganciclovir hydrochloride 50 mg/mL oral solution powder, 100 mL, by Ajanta Pharma USA Inc. The label includes storage instructions, preparation directions for the oral solution, discard timing, and NDC 27241-159-19. The product is for prescription use only and marketed by Ajanta Pharma USA Inc., Bridgewater, NJ.*

FDA Label Image

Valganciclovir Carton

Packaging label for Valganciclovir for Oral Solution 50 mg/mL by Ajanta Pharma USA Inc. The label indicates the product is a 100 mL oral solution containing 50 mg/mL Valganciclovir hydrochloride equivalent to free base. Directions for preparation and storage are included, along with warnings to store the dry powder and constituted solution under specified temperature conditions and discard unused portions after 49 days.*

FDA Label Image

Valganciclovir Fig1

An instructional diagram showing the components of an oral dispenser for valganciclovir hydrochloride powder for solution. The diagram labels the child-resistant cap, bottle adapter, and bottle on the left, and the plunger, barrel, and tip of the oral dispenser syringe on the right.*

FDA Label Image

Formula2 (Valganciclovir Image2)

A mathematical formula labeled "Schwartz Creatinine Clearance" showing clearance in mL per minute per 1.73 square meters calculated as the constant k times height in centimeters divided by serum creatinine in mg/dL.*

FDA Label Image

Valganciclovir Step1

An instructional illustration showing a hand holding a bottle, with an arrow and text indicating to shake the bottle well. This image likely demonstrates how to properly prepare the oral powder for solution of Valganciclovir hydrochloride before use.*

FDA Label Image

Valganciclovir Step10

An instructional illustration showing water droplets falling from a faucet into a measuring cup and a syringe, likely indicating the process of measuring or mixing liquid medication for oral administration.*

FDA Label Image

Valganciclovir Step11

An illustration of a syringe with a measurement scale along its barrel, designed for oral administration. The syringe has a plunger and a narrow tip for dispensing liquid medication.*

FDA Label Image

Valganciclovir Step2

An instructional line drawing showing a bottle with a screw cap being twisted open, indicated by arrows pointing counterclockwise to demonstrate how to open the cap. This illustration is likely intended to guide users on opening the oral powder for solution bottle of Valganciclovir hydrochloride.*

FDA Label Image

Valganciclovir Step3

An illustration showing a syringe with labeled dosage indicator marks in milliliters (mL), used for measuring oral solution doses precisely.*

FDA Label Image

Valganciclovir Step4

An instructional line drawing depicting a hand holding a syringe. The illustration shows the thumb pressing down on the plunger of the syringe, indicating how to administer or withdraw liquid. No other text or product labeling is visible in the image.*

FDA Label Image

Valganciclovir Step5

An instructional illustration showing a hand holding a dosing syringe positioned at the bottle adapter opening of a powder for solution bottle. The image demonstrates where to attach the syringe for oral administration preparation.*

FDA Label Image

Valganciclovir Step6

An instructional illustration showing the preparation of an oral solution from a Valganciclovir hydrochloride powder bottle. The image depicts a hand holding the bottle upside down over a syringe filled with liquid, demonstrating the transfer and mixing process used to prepare the medication for oral administration.*

FDA Label Image

Valganciclovir Step7

An instructional line drawing illustrating a hand holding an oral dosing syringe being inserted into a bottle, showing the proper technique to measure and withdraw medication from the bottle for Valganciclovir hydrochloride powder for solution, oral dosage form.*

FDA Label Image

Valganciclovir Step8

An instructional illustration showing a person using a syringe-like device to administer oral medication, demonstrating the correct method of placing the device into the mouth for oral delivery.*

FDA Label Image

Valganciclovir Step9

Illustration showing a bottle with a child-resistant cap partially unscrewed. The image highlights the cap and neck area of the bottle, likely indicating how to open or close it.*

FDA Label Image

Formula- (Valgavcyclovir Formula 1)

An illustration showing the formula for Mosteller body surface area (BSA) calculation. It depicts the formula: BSA (m²) = square root of [Height (cm) multiplied by Weight (kg) divided by 3600]. This formula is used to estimate body surface area based on height and weight.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.